AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2012
Aug 14, 2012
32870_dirs_2012-08-14_e0a8e07e-3f42-4bc0-b630-f96e0439b2f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2012-08-13
Reporting Person: Kramer Robert (consultant)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-13 | Common Stock | A | 20000 | — | Acquired | 20000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 856043 | Indirect |
Footnotes
F1: Consists of restricted stock units granted under the Second Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
F2: An entity named "RKRAMER, L.L.C." which is wholly owned by Mr. Kramer holds 21.01% of the equity interest in BioPharm, L.L.C. BioPharm, L.L.C. is the direct owner of 856,043 shares of Common Stock. Mr. Kramer disclaims beneficial ownership of these shares for purposes of Section 16, except to the extent of his pecuinary interest of 181,746 units in BioPharm L.L.C. held directly through RKRAMER L.L.C.